Targeted Cancer Therapies & Biofluid Biopsies

Overview

After the last year's event on Biofluid Biopsies in Bengaluru, SELECTBIO brings to you an enhanced version of the same event on Cancer Diagnosis and Treatment. The event  has been entitled "Targeted Cancer Therapies and Biofluid Biopsies". 

The event aims to bring together different fraternities of scientists who are working towards Cancer diagnosis and selective treatment of cancer. Targetted cancer therapies include Cancer immunotherapy, Hormone therapy, ADC, Apoptosis inducers, Angiogenesis inhibitors, ST inhibitors and Gene therapy. The session on Biofluid biopsies will focus primarily on blood-based molecular biomarkers such as Circulating Tumor DNA (ctDNA) for developing biological fluid-based biopsies as well as Circulating Tumor Cells (CTCs) and Protein-based Circulating Biomarkers. 

This event is beneficial for the Scientists who are working or planning to work in the area of extracellular nucleic acids, extracellular vesicles, circulating cell free DNA, microRNA, Liquid biopsies etc. 

This conference will provide scientists and researchers with most up-to-date information & emerging trends in the area of Cancer Therapies and Biofluid Biopsies. Open discussions and break-out sessions on key thematic areas are sure to energize the participants in defining the Targetted Cancer Therapies and Circulating Biomarkers Landscape, especially in the Indian context.

Venue and Dates: Le Méridien Bangalore Hotel, Bengaluru, India on May 25-26, 2017

Sponsorship Options: Companies willing to participate in this event as Sponsors should contact the Exhibition Manager. Sponsorship options with Delegate Participation are also available.